Stock PRCT PROCEPT BIOROBOTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Real-time Estimate Cboe BZX
Other stock markets
 12:34:18 2024-05-15 EDT 		5-day change 1st Jan Change
67.88 USD +3.94% Intraday chart for PROCEPT BioRobotics Corporation +11.63% +60.77%
05-06 Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating MT
05-06 PROCEPT BioRobotics Corporation Announces Long-Term, Real-World Data Showing the Benefits of Aquablation Therapy for the Treatment of Symptomatic Prostatic Hyperplasia CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
GL
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
GL
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
AQ
PROCEPT BioRobotics : AUA 2024 Investor Presentation
PU
PROCEPT BioRobotics : 2024 AUA Investor Day
PU
PROCEPT BioRobotics : Q1 2024 Procept BioRobotics Earnings Conference Call
PU
PROCEPT BioRobotics : Investor Presentation – May 2024
PU
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
GL
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
AQ
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
GL
PROCEPT BioRobotics : UK Modern Slavery Transparency Statement
PU
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
GL
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
GL
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
GL
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
GL
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
GL
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
AQ
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
GL
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
GL
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRCT Stock
  4. News PROCEPT BioRobotics Corporation
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW